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Abstract 
 
Radiotherapy puts bones at risk of developing osteonecrosis. Irradiation has an 
impact on the viability as well as the differentiation capacity of mesenchymal 
stem cells (MSC), which play a pivotal role in bone regeneration.  
 
To investigate the effect of irradiation on MSC, human bone-derived MSC were 
irradiated in vitro. With increasing doses the cells’ self-renewal capabilities were 
greatly reduced. Notably however, mitotically stalled cells were still capable of 
differentiating into osteoblasts and preadipocytes. Next the pigs mandibles were 
subjected to fractionized radiation of 2x9 Gy within one week. This treatment 
mimicks that of a standardized clinical treatment regimen of a head and neck 
cancer patient (30x2 Gy). Fractures, which had been deliberately generated and 
subsequently irradiated showed retarded osseous healing. When isolating MSC 
from irradiated sites at different time points post irradiation, no significant 
changes in comparison to cells derived from un-irradiated specimens regarding 
proliferation capacity and osteogenic differentiation potential became apparent. 
 
Therefore, pig mandibles were irradiated with 9 and 18 Gy in vivo, and MSC 
were isolated immediately afterwards. No significant differences between the 
untreated and 9 Gy -irradiated bone with respect to proliferation and osteogenic 
differentiation were unveiled. Yet, cells isolated from 18 Gy irradiated specimens 
exhibited a reduced osteogenic differentiation capacity, and during the first two 
weeks proliferation rates were greatly diminished. Thereafter, cells recovered 
and showed normal proliferation behaviour. 
 
These findings imply that MSC can cope with irradiation up to high doses in vivo, 
and could be implemented in future therapeutic concepts to protect from 
osteonecrosis.  
 
(250 words) 
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Introduction 
Radiotherapy bears the risk osteonecrosis, which is the most dreaded adverse 
side effect in treatment of head and neck cancer, one of the most common 
cancers worldwide [1]. During osteonecrosis, an impaired fibroblastic activity 
plays a decisive role, whereby the bony matrix is gradually converted into fibrous 
tissue [2]. In parallel, osteoblastogenesis becomes dysregulated leading to 
insufficient proliferation of osteoblasts. In consequence, this impediment often 
results in a high rate of myofibroblast proliferation within irradiated bone and 
surrounding tissues. It is generally assumed that irradiation causes a direct 
damage of tissue-borne multipotent progenitor cells. In fat, due to the massive 
generation of reactive oxygen species (ROS), it leads to the destruction of 
endothelia. This in turn initiates an acute immune response through cytokine 
release followed by an increased production of ROS via the recruitment of 
phagocytes. Vascular thrombosis and endothelial cell destruction eventually 
results in necrosis of microvascular structures, local ischemia, and consequently, 
tissue loss [2]. 
 
Investigations in the past demonstrated that irradiated bone can be supported by 
growth factors, although the response of cells residing in bone is decreased and 
their supply through a degenerating vascular system is compromised. Application 
of cytokines, such as bone morphogenetic proteins can greatly enhance bone 
regeneration of irradiated bone [3]. Besides other cells, also MSC respond to 
these type of cytokines [4]. Whether dormant MSC are capable of coping with 
radiation induced damage and are thus able to sustainingly contribute to wound 
healing and tissue regeneration after irradiation, is currently unknown. 
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Material & Methods 
Isolation and cultivation of mesenchymal stromal cells 
Human MSC were isolated from iliac bone biopsies, cultivated in long-term 
culture as described previously [5]. MSC from Sus scrofa domestica were 
harvested from cancellous and compact bone as well as from the periosteum of 
the mandible and the iliac crest. Samples were reduced in size to approximately 
20 to 100 mm³ under sterile conditions. The specimens were stored in growth 
medium (minimum essential medium (MEM, GIBCO-BRL) containing 10 % fetal 
calf serum (FCS, Invitrogen), 100 units/mL penicillin and 100 µg/mL 
streptomycin) and transported at room temperature. In a sterile work cabinet, the 
liquid was removed and the bone pieces were inserted into a pipette tip with its 
tappering end sitting in a 1.5 mL reaction tube, both within a 15 mL tube. This 
tube was centrifuged for 1 minute at 400 x g to collect the marrow. After 
centrifugation, the remaining pieces were treated with collagenase (2.5 mg/mL in 
MEM, Sigma) for 2 – 3 hours at 37 °C (Heraeus, Hera Cell 240) 20% O2 and 5% 
CO2 to render cells free from the tight extracellular meshwork covering the bony 
surface. The treated specimens were again centrifuged for 1 minute at 400 x g. 
The cell pellet was resuspended in growth medium as described above by gentle 
aspiration through syringe needles of different gauge sizes. In case of 
agglomeration of bone, bone marrow and cells, the fluid was separated from the 
rest by means of a 100 µm nylon mesh filter. Thereafter the resuspended cells 
were loaded on a Ficoll-Paque Plus® gradient (Amersham Biosiences) and 
centrifuged at 2500 × g for 30 minutes. The ratio between the resuspended cells 
containing liquid and those harvested after the Ficoll-Paque Plus® gradient was 
1:1. The cells were harvested from the interphase (density < 1.075 g/mL). In 
order to remove the Ficoll-Paque Plus®, the cells were washed with growth 
medium and recovered by centrifugation at 1500×g for 15 minutes. The purified 
cells were further cultivated at 3% O2 and 5% CO2 (Thermo Electron Corporation 
3110) at a cell density of 0.2 – 0.5x10E6 cell/cm2. After 24 hours, the non-
adherent cell fraction was removed by washing twice with PBS at 37 °C. The 
medium was changed every 3 to 4 days. After the primary culture had reached 
approximately 30–50% confluency, the culture medium was removed and the 
cells were washed twice with PBS for 3 minutes at the 3 % - O2. Thereafter PBS 
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was removed and the cells were treated with 0.05% trypsin / 1mM EDTA 
(GIBCO) for 5 minutes at 37°C. Cells were harvested, washed once in media and 
further expanded at a density of 50 cells / cm2. The number of population 
doublings during every passage was accounted.  
 
Irradiation of cultivated mesenchymal stromal cells.  
Cells were grown in 25 cm2 flasks (2 cm in height) to a confluency of 50% and 
treated with 6 MeV photons, which are commonly used in clinical radiotherapy for 
treatment of cancer patients (ELEKTA Synergy Linear Accelerator; serial 
number: 131431, ELEKTA Oncology Systems installed at the Department of 
Therapeutic Radiology and Oncology / Medical University Innsbruck). For 
radiation of cell probes, an experimental setup was chosen which guaranteed 
broadly homogeneous dose delivery to the cell probes. The flasks were 
completely filled with medium. Four flasks were placed on a staple of Perspex as 
well as surrounded by Perspex and covered with a slab of 1 cm super flab 
material at a source-surface-distance of SSD=100 cm. Cell probes were 
irradiated with energy doses from 3 up to 18 Gy. 
 
Flow cytometric analysis 
Cell viability was examined with the aid of an argon laser-equipped flow 
cytometer (FACSCanto, Becton Dickinson) by monitoring 7-AAD fluorescence 
together with monitoring forward/ and side scattering in combination with the 
AnnexinV method as described previously [6]. Briefly, staining was performed as 
follows: cells were washed with PBS and stained with 20 µg/ml 7-AAD for 40 
minutes at 37°C. Thereafter cells were washed with AnnexinV binding buffer (10 
mM HEPES/NaOH pH 7.4, 140 mM NaCl, 2.5 mM CaCl2) and stained with 5 μL 
AnnexinV-FITC (Becton Dickinson) in 100 μL AnnexinV binding buffer for 15 
minutes at room temperature. Staining was stopped by adding 400 μL AnnexinV 
binding buffer. Data were analyzed with the aid of FACSDiva Software (Becton 
Dickinson). Cell cycle phases were assessed by analysing the amount of nuclear 
DNA by staining permalized cells with propidium iodide: cells were detached from 
the dishes as described and resuspended in de-ionized water containing 0.1% 
Triton X-100 and 50 µg/mL propidium iodide [7]. The proportions of each cell 
cycle stage were calculated with the aid of Cell Quest Pro (BD Biosciences). 
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Osteogenic and adipogenic differentiation in vitro 
Human MSC were stimulated to differentiate in vitro as described previously [5]. 
Differentiation capacity was assessed in quadruplicates by initially growing cells 
for 10 days at 3% O2 and 5% CO2 (Thermo Electron Corporation 3110) and 
37 °C in growth medium, and thereafter incubating the cells for 21 days with 10 
mM β-glycerol phosphate disodium salt pentahydrat (Fluka, Vienna), 10 nM 
dexamethasone (Sigma Aldrich, Vienna), and 50 µg/ml 2-Phospho-L-ascorbic 
acid tri-sodium salt (Fluka) in growth medium at 37 °C, 20% O2 and 5% CO2  
(Hera Cell 240, Heraeus). Eventually the cultures were fixed with 4% 
formaldehyde in PBS. After 5 minutes the specimens were washed twice with 
PBS, pH4. Then the cell layer was stained with Alizarin Red, pH4.1 for 20 
minutes. Excessive stain was removed by several washing steps with PBS, pH4. 
For further analysis, the specimen was kept in PBS, pH4.0. The following 
classification was used to determine the differentiation grade: grade 3 – more 
than 60% cells engulfed by mineralized matrix; grade 2 - 40 – 60%; grade 1 - 
less than 40%; grade 0 – no differentiation in reference to negative control [5]. 
 
Mandible irradiation 
All animal experiments were performed only after permission by the Austrian 
Government and National Ethics Committee (permission number: BMBWK-
66.011/0143-BrGT/2006) and conducted in concordance to the EU directive 
86/609/EEC.  
 
To ensure broadly homogeneous dose delivery in the targeted volume of pig 
mandible in vivo, irradiation treatment was performed according to a 
standardized clinical workflow: first, the pig’s head and in particular the jaws, 
separated with a bite block and placed in treatment position was examined by 
computed tomography (CT); next with the aid of the clinical treatment planning 
system, PrecisePLAN® (ELEKTA Oncology Systems, Crawley, UK) a 
standardized 3D model was compiled on the basis of the CT data set to correctly 
juxtapose two opposing wedged fields of 7 x 3 cm, thereby yielding a widely 
homogenous dose distribution during irradiation. Pig mandibles were irradiated 
with energy doses of 9 Gy and one week later another fraction of 9 Gy, which 
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altogether corresponds to a biologically effective dose of 60 Gy. Proper 
positioning of the radiation field was controlled by generating electronic portal 
images of each radiation field. 
 
Under general anaesthesia a total of 20 pigs underwent an iatrogenic unilateral 
mandibular fracture. The fractures were stabilized with reconstruction plates and 
locking screws in general anaesthesia (Synthes 2.4, Synthes Austria, Salzburg, 
Austria). In the irradiation group (16 pigs) the fracture was set four weeks after 
irradiation, which followed the protocol described above. The irradiated pigs were 
sacrificed either right after irradiation, or 4, 5, 6, 8 or twelve weeks after 
irradiation. The non-irradiated pigs were sacrificed 1, 2, 4 and 8t weeks after the 
surgical treatment.  
 
Histology 
Biopsies were embedded in Technovit 9100 Neu (Heraeus Kulzer, Hanau, 
Germany) as described previously [4]. Performing the sawing and grinding 
technique, described by Donath et al. [8], histological sections of the fracture 
gaps were prepared with a thickness of 12 µm in average. Toluidin blue O 
staining was performed to assess the healing capacity of the irradiated and non 
irradiated fracture sites. 
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Results 
Mesenchymal stromal cells (MSC) are rapidly proliferating when cultured in 
media containing high proportions of fetal bovine serum. When grown at low 
density, MSC readily form colonies, and they are capable of differentiating into 
multiple lineages when induced by appropriate means.  
 
After treatment with increasing doses of ionizing radiation, cultured human 
mesenchymal stromal cells (hMSC), which had been derived from bone of 
systemically healthy individuals and which exhibited the above mentioned 
properties, exhibited increasing cell death rates (Figure 1). Colony formation was 
highly suppressed after treatment with doses of more than 9 Gy. When receiving 
12 Gy or more, many cells survived and could actually be further differentiated 
into adipogenic and osteogenic precursors when incubated in appropriately 
stimulating media (data not shown). An effective dose of 18 Gy resulted in a 
greatly enhanced cell death rate. 
 
These initial findings were corroborated with MSC derived from mandibular bone 
of pigs, which had been implemented as controls in experimental studies 
regarding irradiation treatment, osseous implant healing and induced 
osteoradionecrosis (Figure 2). In course of this in vivo experiment, in which the 
jaws of experimental animals were subjected to fractionated radiation of 2x9 Gy, 
which closely resembles the biologically effective dose of a standardized clinical 
treatment regimen for cancer therapy, we observed that an artificial fracture, 
which had been deliberately generated and subsequently treated with 
osteosynthesis plates and screws, showed retarded osseous healing (Figure 3).  
 
This observation prompted us to investigate, whether in vivo irradiated MSC 
remain vital. In order to determine the impact of ionizing radiation on MSC within 
bone and bone marrow, mandible biopsies were taken from living animals 
directly after irradiation with 9 or 18 Gy. Notably, the long-term proliferation 
capacity of MSC isolates, which had actually been irradiated with 9 or 18 Gy was 
comparable to those of non-irradiated counterparts (Figure 4A). The number as 
well as the osteogenic potential of those MSC that had been isolated from 
mandibular bone irradiated with 18 Gy was greatly diminished (Figure 4 B, C). 
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When the MSC were isolated 4, 5 or 6 weeks post radiatio with 2 x 9 Gy, which 
accounts for a biological effective dose of 60 Gy, their respective number (Figure 
5) as well as their long-term proliferation capacity (Figure 6) was 
indistinguishable from MSC isolated from non-treated control groups.  
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Discussion 
MSC exhibit a high proliferation potential and a multipotent differentiation 
capacity [9]. In recent years many scientists were able to isolate MSCs from a 
large variety of specialized tissues. This naïve cell type could also be 
successfully differentiated in vitro into various tissue-specific precursors with 
phenotypes closely resembling that of osteocytes, chondrocytes, smooth muscle 
cells, skeletal muscle cells, cardiac muscle cells, neuronal cells, insulin producing 
cells, adipocytes, keratinocytes and endothelial cells. Inevitable damages during 
life-time, or other, yet intended harmful events during medicinal therapies may 
activate dormant stem cells in their niches, and it is also assumed that MSCs 
contribute to the regeneration of bone and bone marrow after injury in vivo 
through proliferation and controlled differentiation.  
 
Harmful biological effects of irradiation are mediated via highly reactive radicals - 
such as the water ion H2O+ or the hydroxyl radical OH·, both of which are freely 
diffusible over cellular membranes and thus can damage any biomolecular entity, 
most important in this context DNA [10]. Cells are more radiosensitive during the 
M and G2 phase of the cell cycle, yet being most resistant in the late S phase 
[11]. The cell cycle of cancer cells is shorter than that of normal cells. 
Interestingly, cells residing in oxygenized tissues are 2 to 3 times more sensitive 
to radiation than cells at anoxic conditions [12], and in their regeneration phase 
after irradiation, normal somatic cells often proliferate faster. 
 
In the treatment of head and neck cancer, osteoradionecrosis is a common 
consecutive complication of irradiation, which preferably occurs in the mandible 
[13]. It is conceivable to stimulate healing of irradiated bone through the 
application of cytokines such as bone morphogenetic protein (BMP), or vascular 
endothelial growth factor (VEGF) since it is well known that osseous bone 
healing in vivo is greatly enhanced by such bioactive factors. It is generally 
accepted that MSCs are responsive to BMPs [14-17]. As the influence of 
irradiation on the fate and proliferation of MSCs is only scarcely investigated, we 
first monitored the changing properties of cultured MSC, which were derived from 
porcine irradiated bone, by assessing their clonogenic growth potential, which 
after low density seeding serves as a reliable method to quantify the cell pool that 
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bears stem cell-like qualities. This is considered a good quantitative measure for 
the so-called stemness. Compared to non-irradiated controls, secondary colony-
forming potentiality steadily decreased with increasing dosage, while the 
osteogenic and adipogenic differentiation of irradiated cells remained greatly 
unimpaired after the application of a high dose of 18 Gy, which corresponds to a 
biological effective dose of 60 Gy. These results are in good concordance with 
observations of Clavin et. al., who irradiated murine MSC with 0, 2, 6, and 12 Gy 
in vitro [18]. The cellular proliferation was clearly diminished after application of 
12 Gy while adipogenic and osteogenic differentiation could still be achieved. 
Jing Li et. al. however reported that human MSC when irradiated with a single 
dose of 2, 4, 8 and 12 Gy in suspension and not as an adherent monolayer first 
ceased growth but restored their proliferation rate to normal levels after two 
weeks. Osteogenic and adipogenic potential was decreased with increasing 
doses of radiation [19]. Yet comparable in vivo data are missing up to now. 
 
Considering the fact that bone marrow is a complex in vivo environment with 
many interactions of different cell types at various stages of differentiation, and 
secondly the marrow cavity being a complex three-dimensional structure, a 
scene that could be hardly re-enacted with cells in culture, we next studied the 
fate of MSC after irradiation in vivo. For that purpose, pig mandibles were 
irradiated with either 9 or 18 Gy, dosages which resulted in a greatly retarded 
osseous healing at the site of an artificial fracture. In order to examine the rate of 
damage in tissue-borne MSC, the animals were sacrificed immediately after 
irradiation and cells were isolated. The self renewal property and osteogenic 
potential of MSCs was clearly diminished after irradiation with a dose of 18 Gy. 9 
Gy had only little impact on the MSC, which is in stark contrast to our observation 
regarding radiation sensitivity of in vitro cultured MSC. During common 
radiotherapy in the clinics, patients are subjected to a fractionized treatment 
regimen thereby receiving a biologically effective dose of 60 Gy. Working along 
these lines, we expected that an equivalent dose would lead to a sustainingly 
lasting effect on MSC in the animal model. In line with this assumption we 
actually accounted retarded bone healing during the recovery phase after 
treatment and also noticed 4 weeks post radiation, that the blood vessel density 
was greatly reduced in bone and muscle at irradiated sites (unpublished results). 
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Yet, viable MSC could be successfully isolated at several timepoints up to 8 
weeks post radiation. The MSC number was comparable to non-irradiated control 
samples, their long-term proliferation potential was closely resembling that MSC 
from untreated bone and these cells also differentiated along the osteogenic 
lineage. Given these observations, radiation sensitivity appears to be greatly 
attenuated in MSC in vivo, which may be either due to intrinsic preventive 
measures such as enhanced repair mechanisms, or due to exogenous protective 
means of the stem cell niche. Cellular mechanism of radioresistance have been 
proposed for MSC by Chen et al., who demonstrated that MSCs exhibit high 
antioxidant ROS scavenging capacities together with an enhanced activity of the 
DNA double strand break repair system [20].  
 
Fibrosis is considered key in the development of irradiation-related changes of 
bone [21]. In this context, hypoxia does not appear to be critical but is more a 
consequence of fibrosis in irradiated tissue [2]. Early after radiation, changes in 
endothelial cells go along with an acute inflammatory response, as endothelial 
cells become damaged directly through physical damage as well as through the 
action of ROS and free radicals. Injured endothelial cells produce chemotactic 
cytokines that increase the inflammatory response, which results in further ROS 
production. The destruction of endothelial cells together with micro-thrombosis 
results in local ischemia and the loss of the natural endothelial cell barrier. At that 
point myofibroblasts appear and persist [2], which in due course leads to 
fibroatrophic tissue layers, which are fragile and severely vulnerable. Yet our 
present study suggests that these tissues contain fully functional MSC, which 
may thus contribute to bone healing and regeneration and also take an active 
part in supporting and regulating hematopoeisis and thus sustaining organismic 
immune function.  
 
Consistent with the notion that MSC survive radiation therapy, Friedenstein et. al. 
reported earlier that fibroblastic colony-forming units (CFU-F) reached normal 
values 25 days after whole body irradiation [22]. The notion of enhanced in vivo 
radioresistance of MSC was further substantiated by the observation that in 
patients, who underwent allogeneic bone marrow transplantation after irradiation, 
mesenchymal cells remained host-specific and virtually no transplanted stroma 
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cells were capable to home and engraft into the patients bone marrow; at the 
same time the entire hematopoietic system could be restored by donor-derived 
cells [23]. Besides these observations yet another conceptional view emerged, 
which refers to the possibility that undisturbed MSC residing in distant body parts 
are being mobilized and in a targeted fashion may engraft into lesioned tissues 
and empty niches. Mice that have been subjected to total body irradiation with 
3.5 Gy and subsequently received hMSCs intravenously showed indeed 
enhanced engraftment into bone marrow, muscle, brain, heart, lungs and liver 
when compared to unirradiated litter mates [24]. Similar observations have been 
reported after low dose irradiation of tumors, where the recruitment of MSC into 
the tumor microenvironment was also increased [25].  
 
A recently proposed concept [26, 27] which takes into account evidences that 
MSC-like cells reside in or close to the vessel wall, not only elegantly explains 
the broad tissue distribution of MSC. Yet in extrapolation of this privileged 
position, it is thus conceiveable that MSC contribute to vessel stability and, 
generally spoken, to tissue homeostasis [28]. In turn it is highly likely that during 
degeneration of blood vessels, MSC are being released into injured tissue, which 
is in line with our findings, demonstrating that MSC behave unaffected after 
irradiation [29]. It is further highly likely that in this case MSC become activated 
and proliferate whereby they also generate soluble bioactive factors. Besides 
increasing cellular mass, MSC secretion may in turn contribute to repair and/or 
regeneration of the injured tissue. By now, it became a well accepted paradigm 
that MSC are capable of modulating immune surveillance, thus controlling 
negative interferences of intruding T- and B-lymphocytes within the injury site 
[29]. By this token, MSCs may not only be a key in repair but even more in 
preservation of the affected tissue. 
 
In conclusion, the here presented observations on cellular properties of MSCs 
after irradiation encompass analyses performed in vitro, in vivo and ex vivo, 
clearly demonstrating that MSC bear in vivo radioprotective activities higher than 
commonly believed. This evidence supports the notion that tissue-resident MSC 
can be effectively induced to promote bone healing after irradiation treatment, 
and thus the radioprotective property of MSC should be further considered in the 
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context of future therapeutic concepts. Further research is however required to 
determine whether the protective activity is based on intrinsic mechanisms or due 
to structural determinants of the niche or the surrounding tissues, or lastly, 
whether MSC from undisturbed sites are being activated to migrate and engraft 
to irradiated lesions.
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Figure legends 
 
Figure 1: Irradiation of in vitro cultivated human mesenchymal stromal cells 
derived from cancellous bone of the iliac crest. (A) Irradiation of proliferating cells 
with the indicated dosage showed an impact on cell cycle progression of the 
surviving cell fraction. Cell survival (B) as well as colony formation (C) was 
decreased after irradiation treatment (n=3). 
 
Figure 2: Culture and in vitro osteogenic differentiation of primary porcine 
mesenchymal stromal cells. (A) Fibroblastoid cells, which exhibited firm plastic 
adherence, clonogenic growth and multipotential differentiation capacity, were 
isolated from mandibular bone, bone marrow and periosteum as well as from 
cancellous bone of the iliac crest. (B, C) Osteogenic differentiation potential 
decreased after irradiation at the indicated dosage (for grading in panel C, see 
left panel, scale bar equals 1 cm).  
 
Figure 3: Fracture healing in irradiated mandible of Sus scrofa domestica. Bone 
healing was investigated 8 weeks after a fracture gap was set. Samples A and C 
were irradiated, B, D are untreated controls. Representative examples of slow or 
poor healing (A, B) juxtaposed to a more rapid course (C, D) in both irradiated (A, 
C) and control mandibular bone; dashed line marks the former edge of the 
fracture gap (FG); connective tissue (CT) stains blue, local bone is labeled LB.  
 
Figure 4: Properties of primary porcine mesenchymal stromal cells isolated from 
the mandible directly after irradiation with the indicated effective biological 
dosage. (A) The proliferation potential was monitored in long-term culture. (B) 
Colony formation was accounted in low density secondary culture. (C) After 
irradiation and subsequent cultivation in the presence of osteogenic induction 
medium, the differentiation potential was assessed (for grading see left panel), 
n=3.  
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Figure 5: Clonogenic growth of porcine mesenchymal stromal cells isolated from 
the mandible after fractionated irradiation with 2x9 Gy. (A) Colony formation of 
primary cultivated cells isolated 4, 5 and 6 weeks post irradiation and (B) 
integration of data accounted from all primary cultures isolated at the latter time 
points. 
  
Figure 6: Proliferation potential of porcine mesenchymal stromal cells. (A) 
Growth kinetics of cells were isolated from the mandible 4 weeks after 
fractionated irradiation with 2x9 Gy, and grown in long-term culture 
(representative examples). (B) Proliferation index of cells isolated 4, 5 and 6 
weeks post irradiation during their early stages of long-term cultures and 
integration of data accounted from all long-term cultivations. (C). 
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